Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 2;5(6):593-601.
doi: 10.1002/bco2.351. eCollection 2024 Jun.

'It Just Makes Sense to Me': A qualitative study exploring patient decision-making and experiences with prostate MRI during active surveillance for prostate cancer

Ryan Sutherland  1 , Cary P Gross  2   3   4 , Xiaomei Ma  2   3 , Farah Jeong  5 , Tyler M Seibert  6   7   8 , Matthew R Cooperberg  9   10 , William J Catalona  11 , Shellie D Ellis  12 , Stacy Loeb  13   14 , Dena Schulman-Green  15 , Michael S Leapman  2   3   16
Affiliations

'It Just Makes Sense to Me': A qualitative study exploring patient decision-making and experiences with prostate MRI during active surveillance for prostate cancer

Ryan Sutherland et al. BJUI Compass. .

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] BJUI Compass. 2024 Dec 30;5(12):1324-1329. doi: 10.1002/bco2.482. eCollection 2024 Dec. BJUI Compass. 2024. PMID: 39744071 Free PMC article.

Abstract

Introduction: Although prostate magnetic resonance imaging (MRI) is commonly used in the diagnosis, staging and active surveillance of prostate cancer, little is known about patient perspectives on MRI.

Methods: We performed a qualitative study consisting of in-depth, semi-structured interviews of patients with low- and intermediate-risk prostate cancer managed with active surveillance. Interviews focused on experiences with and knowledge of prostate MRI and MRI-ultrasound fusion biopsy during active surveillance. We purposively sampled patients who received prostate MRI as part of their clinical care, conducted interviews until reaching thematic saturation and performed conventional content analysis to analyse data.

Results: Twenty patients aged 51-79 years (mean = 68 years) participated in the study. At diagnosis, 17 (85%) had a Gleason grade group 1, and three (15%) had a grade group 2 tumour. Overall, participants viewed prostate MRI as a valuable tool that accurately localizes and monitors prostate cancer over time, and they considered prostate MRI central to active surveillance monitoring. We identified five thematic categories related to MRI use: (1) the experiential aspects of undergoing an MRI scan; (2) the experience of visualizing one's own prostate and prostate cancer; (3) adequacy of provider explanations of MRI results; (4) confidence in prostate MRI in decision-making; and (5) the role of prostate MRI in longitudinal follow-up, including an interest in using MRI to modify the timing of, or replace, prostate biopsy.

Conclusion: Patients value prostate MRI as a tool that enhances their confidence in the initial diagnosis and monitoring of prostate cancer. This work can inform future studies to optimize patient experience, education and counselling during active surveillance for prostate cancer.

Keywords: active surveillance; patient‐centered research; prostate MRI; prostate cancer; qualitative research.

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. Hamdy FC, Donovan JL, Lane JA, et al. 10‐year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016;375(15):1415–1424. 10.1056/NEJMoa1606220 - DOI - PubMed
    1. Loeb S, Curnyn C, Fagerlin A, Braithwaite RS, Schwartz MD, Lepor H, et al. Informational needs during active surveillance for prostate cancer: a qualitative study. Patient Educ Couns. 2018;101(2):241–247. 10.1016/j.pec.2017.08.022 - DOI - PMC - PubMed
    1. Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, Davis JW, et al. Clinically localized prostate cancer: AUA/ASTRO guideline, part II: principles of active surveillance, principles of surgery, and follow‐up. J Urol. 2022;208(1):19–25. 10.1097/JU.0000000000002758 - DOI - PubMed
    1. Kim SP, Karnes RJ, Mwangi R, van Houten H, Gross CP, Gershman B, et al. Contemporary trends in magnetic resonance imaging at the time of prostate biopsy: results from a large private insurance database. Eur Urol Focus. 2021;7(1):86–94. 10.1016/j.euf.2019.03.016 - DOI - PMC - PubMed
    1. Leapman MS, Wang R, Loeb S, Seibert TM, Gaylis FD, Lowentritt B, et al. Use of monitoring tests among patients with localized prostate cancer managed with observation. J Urol. 2023;209(4):710–718. 10.1097/ju.0000000000003159 - DOI - PubMed

LinkOut - more resources